企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
DuChemBio Co, LTD was established as a company specializing in the development, manufacture, and sale of radiopharmaceuticals for the diagnosis and treatment of cancer and brain diseases, and it operates its business on the basis of a stable pharmaceutical supply chain, holding the largest number of PET-CT radiopharmaceutical items in Korea and operating the largest number of manufacturing sites in Korea, 12 in total, including six GMP-certified pharmaceutical manufacturing sites. Radiopharmaceuticals, the business the company operates, are pharmaceuticals under the Pharmaceutical Affairs Act composed of radioactive isotopes that emit radiation and drugs (compounds, antibodies, peptides, etc.) that carry the radioactive isotopes to the diseased area.
代表理事
Kim Sangu
成立日期
2002年11月6日
法人类型
韩国创业板
行业分类
Manufacture of synthetic drug and other finished medicaments
法人注册号
11011-2647604
营业执照号
105-86-50172
电话号码
02-332-4868
传真号码
02)332-4768
公司地址
81 Wausan-ro, Mapo-gu, Seoul
产品与服务
评论